(Q39472392)

12 September 2017

title

Mechanism of the antidepressant action of electroconvulsive therapy (English)

1 reference

12 September 2017

D G Grahame-Smith

1

1 reference

12 September 2017

A R Green

series ordinal

2

1 reference

12 September 2017

D W Costain

series ordinal

3

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 February 1978

1 reference

12 September 2017

1 reference

12 September 2017

volume

1

1 reference

12 September 2017

issue

8058

1 reference

12 September 2017

page(s)

254-257

1 reference

The Royal College of Psychiatrists' Memorandum on the use of Electroconvulsive Therapy. Part 1-Effectiveness of ECT-a review of the evidence

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990495-6

7 January 2021

Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990495-6

7 January 2021

Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990495-6

7 January 2021

Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990495-6

7 January 2021

Quipazine: Its effects on rat brain 5-hydroxytryptamine metabolism, monoamine oxidase activity and behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990495-6

7 January 2021

The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990495-6

7 January 2021

Evidence concerning the involvement of 5-hydroxytryptamine in the locomotor activity produced by amphetamine or tranylcypromine plus L-DOPA

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990495-6

7 January 2021

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990495-6

7 January 2021

Electroconvulsive shock and postsynaptic catecholamine effects: Increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990495-6

7 January 2021

Long-term effects of electroconvulsive shock therapy on synthesis, turnover and uptake of brain monoamines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990495-6

7 January 2021

Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990495-6

7 January 2021

Further observations on the effect of repeated electroconvulsive shock on the behavioural resposes of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990495-6

7 January 2021

Effects of apomorphine and clonidine on rat plasma growth hormone after pretreatment with reserpine and electroconvulsive shocks

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990495-6

7 January 2021

Unilateral electro-convulsive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990495-6

7 January 2021

EXPERIMENTAL STUDIES OF MEMORY IMPAIRMENT AFTER ELECTROCONVULSIVE THERAPY

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990495-6

7 January 2021

A comparison of techniques in electro-convulsive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990495-6

7 January 2021

Controlled Trial of Straight and Modified Electroplexy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990495-6

7 January 2021

Evaluation of convulsive and subconvulsive shock therapies utilizing a control group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990495-6

7 January 2021

Experimental studies of the therapeutic action of electroconvulsive therapy in endogenous depression. The role of the electrical stimulation and of the seizure studied by variation of stimulus intensity and modification by lidocaine of seizure disch

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990495-6

7 January 2021

Elevation of brain GABA concentrations with amino-oxyacetic acid; effect on the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990495-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2990495-6

1 reference

7 January 2021

10.1016/S0140-6736(78)90495-6

Identifiers

DOI

1 reference

release_fz6taf7nkfd3vi2ehadyt5eqty

12 September 2017

Fatcat ID

0 references

1 reference